SLC5A2 and polycystic ovary syndrome: As many HFD‐induced pathological changes resemble neurodegenerative diseases, we speculate that the underlying mechanism for the beneficial effects of the SGLT2 inhibitors on HFD‐induced HPO axis disorders and/or PCOS may be similar to that of improving cognitive decline (Fig. 5).